A total of 139 participants have so far been enrolled in the clinical trial on the use of sleep-aid supplement melatonin as adjuvant treatment for coronavirus disease (COVID-19) in patients with pneumonia, the Department of Science and Technology (DOST) said. (Photo by James Yarema on Unsplash) The...